Survival curve analysis showed that GC patients with high L1CAM expression demonstrated poorer OS (P = 0.009, Supplementary Fig. 1a) and DFS (P = 0.013, Supplementary Fig. 1b) compared with patients with low L1CAM expression. The gene discussed is L1CAM; the disease is gastric cancer.